Pages that link to "Q35836554"
Jump to navigation
Jump to search
The following pages link to Drug-polymer conjugates: potential for improved chemotherapy (Q35836554):
Displaying 50 items.
- The discovery and development of marine compounds with pharmaceutical potential (Q28140149) (← links)
- Expression and Subcellular Distribution of GFP-Tagged Human Tetraspanin Proteins in Saccharomyces cerevisiae (Q28546836) (← links)
- Physical energy for drug delivery; poration, concentration and activation. (Q30412855) (← links)
- Differences in the intracellular fate of free and polymer-bound doxorubicin (Q30729281) (← links)
- Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer (Q31883359) (← links)
- Metabolite-derived artificial polymers designed for drug targeting, cell penetration and bioresorption (Q33226212) (← links)
- Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD). (Q33487784) (← links)
- Making the most of rodent tumour systems in cancer drug discovery (Q33595606) (← links)
- Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer (Q33695523) (← links)
- Immunohistochemical quantification of the vitamin B12 transport protein (TCII), cell surface receptor (TCII-R) and Ki-67 in human tumor xenografts (Q33702468) (← links)
- Polymeric micelles - a new generation of colloidal drug carriers (Q33724244) (← links)
- Bioconjugation in pharmaceutical chemistry. (Q33746346) (← links)
- Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs (Q33746856) (← links)
- Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo (Q33892020) (← links)
- Studies of macromolecular prodrugs of zidovudine (Q33933503) (← links)
- Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers (Q34159154) (← links)
- Inhibition of brain tumor growth by intravenous poly(β- l -malic acid) nanobioconjugate with pH-dependent drug release (Q34241230) (← links)
- Targeted drug conjugates: principles and progress (Q34455170) (← links)
- Combinatorial chemistry and biomedical polymer development (Q34456765) (← links)
- Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability. (Q34489836) (← links)
- Polymer-drug conjugates: recent development in clinical oncology (Q34656003) (← links)
- Polymer-Based Therapeutics (Q34781736) (← links)
- Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis (Q34783018) (← links)
- Targeted drug delivery by thermally responsive polymers. (Q34804805) (← links)
- Immunomodulating activities of soluble synthetic polymer-bound drugs (Q34804827) (← links)
- Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. (Q34971336) (← links)
- The dawning era of polymer therapeutics (Q35128900) (← links)
- In vivo tumor targeting by a NGR-decorated micelle of a recombinant diblock copolypeptide (Q35377628) (← links)
- Drug targeting by macromolecules without recognition unit? (Q35549416) (← links)
- Drug delivery systems: polymers and drugs monitored by capillary electromigration methods (Q35589755) (← links)
- Dual pH- and Temperature-Responsive Protein Nanoparticles (Q36048253) (← links)
- Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin (Q36062855) (← links)
- Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. (Q36136547) (← links)
- CNS drug delivery: opioid peptides and the blood-brain barrier (Q36439195) (← links)
- Polymer conjugates as anticancer nanomedicines (Q36561667) (← links)
- Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs (Q36597647) (← links)
- Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (Review) (Q36643541) (← links)
- Drug-initiated ring-opening polymerization of O-carboxyanhydrides for the preparation of anticancer drug-poly(O-carboxyanhydride) nanoconjugates (Q36899044) (← links)
- Nanoparticle characterization: state of the art, challenges, and emerging technologies. (Q36901928) (← links)
- Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate (Q36920312) (← links)
- Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor. (Q36920351) (← links)
- Covalent polymer-drug conjugates. (Q37002669) (← links)
- Polymeric Nanomedicines Based on Poly(lactide) and Poly(lactide-co-glycolide). (Q37056787) (← links)
- Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery (Q37121790) (← links)
- Peptide-based Biopolymers in Biomedicine and Biotechnology (Q37362252) (← links)
- Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. (Q37467770) (← links)
- Pharmacologic and chemical adjuvants in tumor virotherapy (Q37492540) (← links)
- Polymeric materials for theranostic applications (Q38114360) (← links)
- PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination (Q38281206) (← links)
- Hydrogen-bonded multilayer of pH-responsive polymeric micelles with tannic acid for surface drug delivery (Q38499697) (← links)